Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01673737
Title A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications

Advanced Solid Tumor

lymphoma

Therapies

SAR260301

SAR260301 + Vemurafenib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.